.
Criteria for excluding patients from the study included the fol¬ lowing: (1) (4) life-threatening hypoxemia (O2 saturation <90%, or PaC>2 <60 mm Hg, on a nonrebreathing face mask). Criteria for exit from the study included the following: (1) inability to improve gas exchange, dys¬ pnea, or lethargy; (2) development ofconditions necessitating ETI; (3) hemodynamic or ECG instability; (4) inability to tolerate the face mask because of discomfort; (5) inability to properly fit the face mask; or (6) patient request.
The method of NPPV is shown in Figure 1 pneumonia by clinical and radiographic criteria, and abdominal distention.
The following sequential data were recorded at entrance into the study (baseline) and at 2-to 6-h intervals: (1) 41 (26) 52 (33) Table 4 .
Response to NPPV
The overall response to NPPV is shown in Table 5 . Table 6 . Predicted mortality by APACHE II score.31 (38) 7 (13) 4 (8) 6 (10) 6 (12) 3 (6) 6 (12) 52 *Five patients from group 5 who had NPPV discontinued (see Table 5 ) are not included in this Table. * Intolerance to the mask developed an average of 19.5 h into NPPV.
Complications
As shown in Table 5 (52) or insufficiency (22) . Precipitating conditions are shown in Table 2 . Twenty-five patients (34%) required intu¬ bation (16 responders and 9 nonresponders) for the following reasons: inability to correct gas exchange (12) , inability to improve dyspnea (4) (17) , severe CAP (4), congestive heart failure (5), and others (11 (Fig 1) . In most patients, this Vt target was well toler¬ ated and was adequate for resting respiratory muscles and improving gas exchange (see below). We believe that PSV should be adjusted, as soon as the patient can tolerate it, to obtain the largest exhaled tidal volume (PSV max (27) or without COPD (14 
